Clinical Management of Chronic Kidney Disease
Self-Study Examination
Instructions: After studying the text answer the following true/false or multiple choice questions. Remember, there's only one answer to each question.
a) 1 and 4 b) 2 only c) 2 and 4 d) 4 only
a) Stage 1 b) Stage 2 c) Stage 3 d) Stage 4
a) true b) false
a) 1 and 4 b) 2 and 3 c) 1, 3, and 4 d) 1, 2, and 3
a) protein b) carbohydrate c) fat d) fluid
a) 3 only b) 3, 4, and 5 c) 1 and 2 d) 1, 4, and 5 e) 1, 2, and 3
a) cardiovascular disease b) increasing obesity c) a high fat and high sodium diet d) lack of exercise
a) blacks, whites b) Eskimos, blacks c) Latinos, blacks d) whites, blacks
a) 2 and 4 b) 2, 3, and 4 c) 1 and 3 d) 2 and 5 e) 2, 4, and 5
a) predisposing b) initiating c) progression
a) 1 b) 2
a) cirrhosis b) uncontrolled hypertension c) pregnancy d) cancer
a) have a yearly glucose tolerance test b) be screened for neuropathy c) use sugar substitutes d) follow the DASH diet
a) randomized individuals with intensive therapy had a 37% reduction in microvascular complications b) intensive glucose control was associated with a lower HbA1C over 10 years c) kidney protection was evident with 12 months of the trial d) differences were seen between captopril and atenolol regarding microvascular end points
a) sugar, protein, and sodium b) fats, sugar, and potassium c) protein, phosphorous and potassium d) sodium, calcium and fluids
a) combined therapy decreased proteinuria b) diuretics are effective antihypertensives c) there was no difference in the glomerular filtration rate among the antihypertensive treatments d) risk reduction was greatest among patients with baseline proteinuria > 1 gram/day
a) 5, 10 b) 8, 15 c) 10, 30 d) 15, 25
a) 2, 4, and 5 b) 1, 2, and 3 c) 3, 4, and 5 d) 1, 3, and 5
a) obesity and smoking b) malnutrition and sleep disturbances c) elevating clotting factors and hypertension d) high fat diet and oxidative stress
a) alpha-adrenergic blockers b) beta-adrenergic blockers c) calcium channel blockers d) angiostatin-converting enzyme inhibitors e) diuretics
a) thiazide or loop diuretics b) potassium-sparing diuretics c) osmotic diuretics
a) micralbuminuria b) macroalbuminuria
a) albumin b) circulating iron c) endogenous erythropoietin d) folate and B 12
a) 1 only b) 2, 3, and 4 c) 2 and 4 d) 1, 2, and 4
a) 8.0, 12.2, 60 b) 9.0, 10.4, 40 c) 6.6, 8.2, 30 d) 10.6, 12.8, 20
a) parathyroid hormone b) iron c) dietary protein d) vitamin D
a) dark cola, pancake mix, pizza b) chicken, dried peas , popcorn c) milk, pasta, nuts
a) small intestine b) liver c) kidney d) stomach
a) hypertension b) itching c) a headache d) seizure activity
a) AVGs, AVFs b) AVFs, AVGs
a) infection b) respiratory failure c) blood dyscrasias d) cardiovascular disease
a) choosing an appropriate maintenance dose based on kidney function b) evaluating the excretion rate of the drug c) lowering the dose to prevent acidosis d) assessing the absorption rates
a) primary medical physician b) nephrologist c) Federal Register d) Department of Health and Human Services
a) identifying and screening individuals at risk for CKD b) discussing CKD progression c) treating nutritional disorders d) recommending treatment for diabetes and hypertension